| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 142.409 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 100.861 | 75 |
| GSM780709 | Untreated after 4 days (C3_1) | 98.6899 | 75 |
| GSM780719 | Untreated after 4 days (C1_2) | 161.051 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 114.843 | 77 |
| GSM780721 | Untreated after 4 days (C3_2) | 104.038 | 76 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 95.5155 | 75 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 129.663 | 79 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 114.542 | 77 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 84.9338 | 73 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 128.558 | 79 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 105.426 | 76 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 141.5 | 80 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 105.353 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 128.99 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 159.546 | 81 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 119.544 | 78 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 146.092 | 80 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 154.242 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 129.564 | 79 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 97.8323 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 141.867 | 80 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 138.732 | 80 |